Damaskini Valvi, MD, PhD, MPH Email Damaskini Valvi
- ASSISTANT PROFESSOR | Environmental Medicine & Public Health
Dania Valvi, MD, PhD, MPH, is Assistant Professor in the Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai where she is a member of the Institute for Exposomic Research and the NIH-funded Transdisciplinary Center on Early Environmental Exposures. An environmental epidemiologist, Dr. Valvi is examining how early life and life-course environmental exposures impact health, with a particularly focus on the effects of chemicals and nutritional factors on children’s health and development. She employs novel ‘omics’-based approaches to facilitate the understanding of disease mechanisms and identification of biomarkers for the prevention and early detection of environmental disease. Her recent research in prospective population studies in Spain, the Faroe Islands, United States and elsewhere, has focused on the health effects of chemicals classified as endocrine disruptors, including perfluoroalkyl substances (PFASs), organochlorine pesticides, phenols, phthalates, and metals. She is Co-Investigator on multiple NIH-funded research projects focused on the environmental origins of disease, and the Principal Investigator on a NIEHS funded project examining the metabolic effects and mechanisms of toxicity of early life exposure to PFASs.
Prior to joining Mount Sinai, Dr. Valvi was a research scientist at Harvard T.H. Chan School of Public Health where she also completed a postdoctoral fellowship. She is a member of many professional societies, including the International Society for Environmental Epidemiology (ISEE), The Obesity Society (TOS), the Endocrine Society, and the International Society for Children’s Health and the Environment (ISCHE). She was a guest editor of the International Journal of Environmental Research and Public Health’s Special Issue ‘Maternal and Child Environmental Health and Disease’ and has served as ad-hoc reviewer of manuscripts and study protocols for the CDC/Agency for Toxic Substances and Disease Registry, the National Institute of Environmental Health Sciences (NIEHS) and several international scientific journals in the research fields of Epidemiology, Environmental Sciences, Pediatrics, Endocrinology & Metabolism, and Clinical Medicine.
MD, University of Crete Medical School, Greece
MPH, Pompeu Fabra University and Autonoma University of Barcelona, Spain
PhD, Pompeu Fabra University, Barcelona, Spain
Postdoctoral research fellowship, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Visiting Research Scholar, Gillings School of Global Public Health, University of North Carolina – Chapel Hill, NC, USA
2019 National Institute of Environmental Health Sciences (NIEHS) R21 ES029328
Developmental Exposure to Perfluoroalkyl Substances and Cardiometabolic Outcomes in Adulthood: Potential Links via the Plasma Metabolome.
2016 Hoffman Program on Chemical and Health - Harvard T.H. Chan School of Public Health
Elucidating the role of adipocytokines and insulin-like growth factors in the pathogenesis of metabolic diseases linked to early life environmental exposures.
2015 Harvard – NIEHS Center Facility Access Funds Award
Telomere length dynamics over time in response to persistent pollutant exposure profiles.
2010 Carlos III Health Institute – Predoctoral Fellowship FI10/0399
Effects of Endocrine Disrupting Chemicals on Childhood Growth and Obesity.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Valvi did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.